# OnCo record sobi (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sobi/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sobi" ;
  schema:name "Sobi (Swedish Orphan Biovitrum)"@en ;
  schema:alternateName "CTI BioPharma"@en ;
  schema:description "Sobi is a Swedish rare-disease company whose haematology and oncology supportive products include palifermin (Kepivance) for severe oral mucositis, avatrombopag (Doptelet) and emapalumab (Gamifant)."@en ;
  schema:url <https://onco.cc/companies/sobi/>, <https://www.sobi.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sobi.com> ;
  schema:addressCountry "SE" ;
  onco:drugs <https://onco.cc/drugs/palifermin/>, <https://onco.cc/drugs/emapalumab/>, <https://onco.cc/drugs/pacritinib/> ;
  onco:companies <https://onco.cc/companies/adc-therapeutics/> ;
  onco:terms <https://onco.cc/terms/mucositis/>, <https://onco.cc/terms/thrombocytopenia/> ;
  onco:trials <https://onco.cc/trials/nct07033598/> .
